Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.582
-0.043 (-6.86%)
At close: Dec 4, 2024, 4:00 PM
0.580
-0.002 (-0.38%)
After-hours: Dec 4, 2024, 5:21 PM EST
Bolt Biotherapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue | 9.78 | 7.88 | 5.73 | 1.26 | 0.23 | 0.22 | |
Revenue Growth (YoY) | 35.86% | 37.48% | 354.68% | 445.45% | 7.44% | - | |
Cost of Revenue | 62.07 | 61.54 | 73.12 | 75.66 | 40.36 | 26 | |
Gross Profit | -52.29 | -53.67 | -67.39 | -74.4 | -40.13 | -25.79 | |
Selling, General & Admin | 20.04 | 22.53 | 22.93 | 18.39 | 9.06 | 5.18 | |
Operating Expenses | 20.04 | 22.53 | 22.93 | 18.39 | 9.06 | 5.18 | |
Operating Income | -72.33 | -76.2 | -90.32 | -92.79 | -49.18 | -30.97 | |
Interest & Investment Income | 6.14 | 7 | 2.22 | 0.28 | 0.2 | 0.52 | |
Other Non Operating Income (Expenses) | - | - | - | -6.08 | -11.75 | -0.04 | |
Pretax Income | -65.09 | -69.2 | -88.1 | -98.59 | -60.73 | -30.49 | |
Net Income | -65.09 | -69.2 | -88.1 | -98.59 | -60.73 | -30.49 | |
Net Income to Common | -65.09 | -69.2 | -88.1 | -98.59 | -60.73 | -30.49 | |
Shares Outstanding (Basic) | 38 | 38 | 37 | 33 | 2 | 2 | |
Shares Outstanding (Diluted) | 38 | 38 | 37 | 33 | 2 | 2 | |
Shares Change (YoY) | 1.02% | 1.21% | 12.54% | 1479.05% | 5.46% | 20.76% | |
EPS (Basic) | -1.71 | -1.83 | -2.36 | -2.97 | -28.89 | -15.29 | |
EPS (Diluted) | -1.71 | -1.83 | -2.36 | -2.97 | -28.89 | -15.29 | |
Free Cash Flow | -61.17 | -69.73 | -78.46 | -59.4 | -50.57 | -26.85 | |
Free Cash Flow Per Share | -1.61 | -1.84 | -2.10 | -1.79 | -24.05 | -13.47 | |
Operating Margin | -739.68% | -967.45% | -1576.56% | -7364.13% | -21290.91% | -14404.19% | |
Profit Margin | -665.56% | -878.58% | -1537.76% | -7824.68% | -26289.18% | -14180.00% | |
Free Cash Flow Margin | -625.53% | -885.36% | -1369.47% | -4714.60% | -21891.77% | -12488.84% | |
EBITDA | -70.51 | -74.34 | -88.66 | -91.6 | -48.57 | -30.63 | |
D&A For EBITDA | 1.82 | 1.85 | 1.67 | 1.19 | 0.61 | 0.34 | |
EBIT | -72.33 | -76.2 | -90.32 | -92.79 | -49.18 | -30.97 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.